Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection

Transplant Proc. 1993 Feb;25(1 Pt 1):820-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD / immunology*
  • Antigens, CD7
  • Antigens, Differentiation, T-Lymphocyte / immunology*
  • Cadaver
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Mice
  • Muromonab-CD3 / therapeutic use
  • Recombinant Fusion Proteins / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, CD7
  • Antigens, Differentiation, T-Lymphocyte
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Recombinant Fusion Proteins
  • SDZ CHH 380